NeoGenomics (MEX:NEO) Institutional Ownership: 64.53% (As of Jul. 19, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

MEX:NEO NeoGenomics Inc MEX:NEO
62 GF Score
Price MXN176.40
GF Value MXN479.12
Valuation Significantly Undervalued
! 6 Warning Signs
View Full Analysis

What is NeoGenomics Institutional Ownership?

NeoGenomics MEX:NEO 62 Institutional Ownership is 64.53% as of Jul. 19, 2026. GuruFocus rates MEX:NEO with a GF Score™ of 62/100 and a GF Value™ of MXN479.12 (Significantly Undervalued). The stock has 6 warning signs investors should review.

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, NeoGenomics's institutional ownership is 64.53%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, NeoGenomics's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, NeoGenomics's Float Percentage Of Total Shares Outstanding is 84.95%.

NeoGenomics Institutional Ownership Historical Data

* Premium members only.

The historical data trend for NeoGenomics's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

NeoGenomics Institutional Ownership Chart

NeoGenomics Historical Data

The historical data trend for NeoGenomics can be seen below:

2025-09-30 2025-10-31 2025-11-30 2025-12-31 2026-01-31 2026-02-28 2026-03-31 2026-04-30 2026-05-31 2026-06-30
Institutional Ownership 55.28 55.87 56.99 57.59 62.08 61.34 60.96 62.68 62.33 64.53
MEX:NEO
62GF Score
NeoGenomics Inc MEX:NEO
Institutional Ownership is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

NeoGenomics Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.

What does a Institutional Ownership of 64.53% mean?
NeoGenomics (MEX:NEO) has a Institutional Ownership of 64.53% as of Jul. 19, 2026. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on NeoGenomics and its competitors.
Is NeoGenomics' Institutional Ownership too high?
NeoGenomics' current Institutional Ownership is 64.53%. Overall, NeoGenomics has a GF Score™ of 62/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does NeoGenomics' Institutional Ownership compare to WGS and CDNA?
NeoGenomics' Institutional Ownership of 64.53% can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Institutional Ownership for a Medical Diagnostics & Research company?
A good Institutional Ownership depends on the Medical Diagnostics & Research industry context. However, Institutional Ownership should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Institutional Ownership mean?
A high Institutional Ownership can signal that a stock is expensive relative to its fundamentals. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on NeoGenomics and its competitors. NeoGenomics's current Institutional Ownership is 64.53%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is NeoGenomics stock overvalued right now?
Based on GuruFocus' analysis, NeoGenomics (MEX:NEO) is currently considered Significantly Undervalued. The stock's GF Value™ is MXN479.12, compared to a current price of MXN176.40 — trading 63.2% below its estimated fair value. The current Institutional Ownership is 64.53%. NeoGenomics' overall GF Score™ is 62/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Institutional Ownership calculated?
Institutional Ownership is calculated from a company's financial statements. For NeoGenomics (MEX:NEO), the current Institutional Ownership is 64.53% as of Jul. 19, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is NeoGenomics (MEX:NEO) Overvalued in 2026?

Based on GuruFocus' analysis, NeoGenomics stock appears to be undervalued. The current stock price of MXN176.40 is trading 63.2% below its estimated GF Value™ of MXN479.12. GuruFocus considers NeoGenomics to be Significantly Undervalued.

Key valuation signals for MEX:NEO:

  • Institutional Ownership: 64.53%
  • GF Value™: MXN479.12 vs. price of MXN176.40 (63.2% below fair value)
  • GF Score™: 62/100 with 6 warning signs

No single metric tells the full story. See the MEX:NEO stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

NeoGenomics Business Description

Other Exchanges NEO:USANG9:Germany
Address 9490 NeoGenomics Way, Fort Myers, FL, USA, 33912
NeoGenomics Inc provides oncology diagnostic testing and consultative services which include technical laboratory services and professional interpretation of laboratory test results by licensed physicians or molecular experts in pathology and oncology. The company operates a network of cancer-focused testing laboratories in the United States and the United Kingdom. The company operates in a single segment and derives revenue from clients by providing clinical cancer testing, interpretation, and consultative services, molecular and NGS testing, comprehensive technical and professional services offerings, clinical trials and research, validation laboratory services, and oncology data solutions.
62GF Score

Get the complete analysis for MEX:NEO

Institutional Ownership is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

MXN176.40
Price
MXN479.12
GF Value